Biden executive order lifts ban on using march-in rights to lower drug costs

Max Gelman

Senior Editor

As part of an executive order issued last Friday marketed as promoting economic competition, President Joe Biden directed the government to pause a proposed rule …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Biden executive order lifts ban on using march-in rights to lower drug costs

Max Gelman

Senior Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Trump 2.0 blog: Wayback Machine is insufficient for US health data, judge says

Travere plans to seek expanded label for kidney drug despite failed trial

Biohaven lands priority review on second-chance application for neurodegenerative drug

Pfizer’s prostate cancer data leak shows promising results in early-stage study

FDA puts two Chinese API makers on import alert after failed inspections

Reducing risk in drug development: The importance of validated MRD testing in lymphoid cancers

Biden ex­ec­u­tive or­der lifts ban on us­ing march-in rights to low­er drug costs

Senior Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Biden executive order lifts ban on using march-in rights to lower drug costs